Synairgen

Share on: 
Website: Synairgen
Description: 

Synairgen is a drug discovery and development company focused primarily on severe asthma and COPD. It  uses its differentiating human biology BioBank platform and expertise to discover and develop novel therapies for respiratory disease.

COVID-19: On 20 July 2020, Synairgen plc announced positive results from its trial of SNG001, the Company’s wholly-owned inhaled formulation of interferon beta in hospitalised COVID-19 patients

Location(s): 
Southampton
United Kingdom